Palatin Technologies (PTN) Common Equity (2011 - 2026)
Palatin Technologies' (PTN) quarterly Common Equity came in at $10.6 million in Q1 2026, up 265.83% YoY from $2.9 million in Q1 2025, and down 7.62% on a QoQ basis from $11.5 million in Q4 2025.
Palatin Technologies (PTN) Common Equity (2011 - 2026) Analysis & Trends
Palatin Technologies (PTN) has 16 years of Common Equity data on file, last reported at $10.6 million in Q1 2026.
- Quarterly Common Equity rose 265.83% year-over-year to $10.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.6 million (up 265.83% YoY) and the FY2025 annual result came in at -$4.8 million, down 4184.46% from the prior year.
- Common Equity slipped to $10.6 million in Q1 2026, from $11.5 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $28.1 million in Q1 2022 to a low of -$11.4 million in Q4 2023.
- A 5-year average of $2.9 million and a median of $396399.0 in 2025 frame the typical range for Common Equity.
- The widest YoY moves for Common Equity: up 279.69% in 2025, down 4184.46% in 2025.
- Tracing PTN's Common Equity over 5 years: stood at $11.5 million in 2022, then slumped by 198.73% to -$11.4 million in 2023, then surged by 43.95% to -$6.4 million in 2024, then jumped by 279.69% to $11.5 million in 2025, then dropped by 7.62% to $10.6 million in 2026.
- The last three Common Equity figures came in at $10.6 million (Q1 2026), $11.5 million (Q4 2025), and $396399.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | 9.79 Bn |
| 10 | Palatin Technologies | 40.37 Mn | 40.37 Mn | - | 10.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.59 Mn |
| Dec 31, 2025 | 11.47 Mn |
| Sep 30, 2025 | 396,399.00 |
| Jun 30, 2025 | -4.78 Mn |
| Mar 31, 2025 | -6.39 Mn |
| Dec 31, 2024 | -6.38 Mn |
| Sep 30, 2024 | -7.69 Mn |
| Jun 30, 2024 | -111,497.00 |
| Mar 31, 2024 | 1.58 Mn |
| Dec 31, 2023 | -11.38 Mn |
| Sep 30, 2023 | -6.32 Mn |
| Jun 30, 2023 | -1.98 Mn |
| Mar 31, 2023 | 6.58 Mn |
| Dec 31, 2022 | 11.53 Mn |
| Sep 30, 2022 | 8.45 Mn |
| Jun 30, 2022 | 16.27 Mn |
| Mar 31, 2022 | 28.09 Mn |
| Dec 31, 2021 | 35.20 Mn |
| Sep 30, 2021 | 42.97 Mn |
| Jun 30, 2021 | 49.65 Mn |